Oral Product Line
ChemWerth's goal is to offer the best source – not the first source. Using ChemWerth's APIs, you will receive the fastest FDA approval possible which is critical to your success in the highly competitive generic oral market. Our Regulatory expertise allows for customers to receive FDA approval in 12 to 15 months.
Acitretin
Acyclovir
Alosetron HCl
Anagrelide HCl
Asenapine
Dantrolene Na
Doxercalciferol**
Dronedarone
Drospirenone
Dutasteride
Erlotinib HCl
Ethosuximide USP
Exemestane**
Febuxostat
Hydroxychloroquine SO4 USP**
Imatinib Mesylate
|
Lacosamide
Levoleucovorin Ca
Melbemycin Oxime
Paliperidone
Paricalcitol
Pentosan Polysulfate Sodium
Silodosin
Sirolimus**
Tacrolimus
Tacrolimus Premix
Temozolomide
Tetrabenazine
Tiagabine HCl
Topiramate USP
Valganciclovir HCl
|
** Pending Approval
Items denoted by blue text have been approved in the USA/EP
|
CONTACT CHEMWERTH
For more information about our Oral
products, please complete and submit the
form below. A ChemWerth Representative
will contact you.
|